Owens & Minor (NYSE:OMI) Sets New 52-Week Low - Should You Sell?

Owens & Minor, Inc. (NYSE:OMI - Get Free Report)'s share price hit a new 52-week low on Monday . The stock traded as low as $10.74 and last traded at $10.89, with a volume of 743336 shares traded. The stock had previously closed at $14.24.

Analysts Set New Price Targets

A number of equities research analysts have commented on OMI shares. UBS Group reduced their target price on Owens & Minor from $28.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird decreased their target price on shares of Owens & Minor from $15.00 to $14.00 and set a "neutral" rating on the stock in a research report on Tuesday. Barclays dropped their price target on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a research report on Tuesday, November 5th. Finally, Citigroup lowered their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research report on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $18.50.

Owens & Minor Price Performance

The company's 50-day simple moving average is $13.41 and its 200 day simple moving average is $14.12. The company has a market cap of $667.16 million, a PE ratio of -13.31, a PEG ratio of 0.25 and a beta of 0.48. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.

Insiders Place Their Bets

In related news, CFO Jonathan A. Leon sold 5,282 shares of the company's stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now directly owns 130,822 shares of the company's stock, valued at $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 3.59% of the stock is owned by company insiders.

Hedge Funds Weigh In On Owens & Minor

Several hedge funds have recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in Owens & Minor by 176.8% during the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock worth $44,000 after purchasing an additional 1,780 shares during the period. KBC Group NV grew its position in Owens & Minor by 98.2% during the fourth quarter. KBC Group NV now owns 4,434 shares of the company's stock worth $58,000 after buying an additional 2,197 shares during the period. Meeder Asset Management Inc. raised its holdings in Owens & Minor by 844.1% during the third quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company's stock worth $141,000 after purchasing an additional 8,061 shares during the last quarter. Marshall Wace LLP boosted its position in Owens & Minor by 38.4% during the second quarter. Marshall Wace LLP now owns 11,100 shares of the company's stock worth $150,000 after purchasing an additional 3,077 shares in the last quarter. Finally, Inspire Advisors LLC acquired a new stake in Owens & Minor in the third quarter valued at $217,000. Hedge funds and other institutional investors own 98.04% of the company's stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.